文献
J-GLOBAL ID:201802230666295282
整理番号:18A0621835
酢酸アビラテロン+プレドニゾンによる化学療法転移性去勢抵抗性前立腺癌における無増悪生存期間の予後指標モデル【Powered by NICT】
Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naieve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone
著者 (11件):
Ryan Charles J.
(Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA)
,
Kheoh Thian
(Janssen Research & Development, San Diego, CA)
,
Li Jinhui
(Johnson & Johnson Medical China, Shanghai, China)
,
Molina Arturo
(Janssen Research & Development, Menlo Park, CA)
,
De Porre Peter
(Janssen Research & Development, Beerse, Belgium)
,
Carles Joan
(Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain)
,
Efstathiou Eleni
(The University of Texas MD Anderson Cancer Center, Houston, TX)
,
Kantoff Philip W.
(Memorial Sloan Kettering Cancer Center, New York, NY)
,
Mulders Peter F.A.
(Radboud University Medical Centre, Nijmegen, The Netherlands)
,
Saad Fred
(Centre Hospitalier de l’Universite de Montreal/CRCHUM, Montreal, QC, Canada)
,
Chi Kim N.
(BC Cancer Agency, Vancouver, BC, Canada)
資料名:
Clinical Genitourinary Cancer
(Clinical Genitourinary Cancer)
巻:
16
号:
1
ページ:
72-77.e1
発行年:
2018年
JST資料番号:
W3244A
ISSN:
1558-7673
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)